Biobeat Technologies is an Israeli healthtech company1, headquartered in Petah Tikva1.
It has raised $50M across 1 funding round1; the most recent was a Series B round of $50M1, announced Jan 15, 20261.
Founders: Arik Ben Ishay (CEO) and Raymond W. Cohen (Executive Chairman)1.
Funding history
| Round | Announced | Amount | Lead investors |
|---|---|---|---|
| Series B | Jan 15, 2026 | $50M | Ally Bridge Group, OrbiMed Advisors, Elevage Medical Technologies |
Founders
Investors
Which Israeli startups are similar to Biobeat Technologies?
Sources
- 1FinSMEs, Jan 15, 2026. “Biobeat Raises $50M in Series B Funding”
How much funding has Biobeat Technologies raised?
Biobeat Technologies has raised $50M across 1 funding round.
What was Biobeat Technologies’s latest funding round?
Biobeat Technologies’s most recent round was a Series B round of $50M, announced Jan 15, 2026.
Who founded Biobeat Technologies?
Biobeat Technologies was founded by Arik Ben Ishay and Raymond W. Cohen.
Who has invested in Biobeat Technologies?
Investors in Biobeat Technologies include Ally Bridge Group, OrbiMed Advisors and Elevage Medical Technologies.
Where is Biobeat Technologies based?
Biobeat Technologies is based in Petah Tikva.